Skip to content

Modulating Perioperative EEG Activity with Transcutaneous auricular vagus nerve stimulation to Alleviate Postoperative Sleep Disorders: : a double-blind, randomized clinical trial

Effect of Transcutaneous auricular vagus nerve stimulation on the intraoperative frontal electroencephalography dynamics and postoperative sleep disturbance during gynecological laparoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120222
Enrollment
Unknown
Registered
2026-03-11
Start date
2026-03-15
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disorders (PSD)

Interventions

Trial Group:Transcutaneous auricular vagus nerve stimulation (taVNS): frequency 20 Hz, pulse width 250 µs, left concha cavity electrode, single stimulation for 30 minutes, administered once 1 hour bef
Control Group:Sham transcutaneous auricular vagus nerve stimulation (Sham taVNS): frequency 1 Hz, pulse width 250 µs, left concha cavity electrode, single stimulation for 30 minutes, administered once

Sponsors

Fujian Maternity and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Female patients aged 18–65 years. 2. American Society of Anesthesiologists (ASA) physical status I–II. 3. Body mass index (BMI) 18–30 kg/m^2. 4. Scheduled for elective gynecological laparoscopic surgery with an expected operative time > 1 hour. 5. Preoperative Pittsburgh Sleep Quality Index (PSQI) score <= 7. 6. Willing and able to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Skin breach, infection, or inflammation of the pinna or external auditory canal (including dermatitis/eczema); 2. History of tinnitus, Meniere’s disease, paroxysmal cardiac arrhythmia, or implanted pacemaker/defibrillator; 3. Prior diagnosis of neuropsychiatric disorders (e.g., depression, anxiety disorders, epilepsy, schizophrenia) or sleep disorders (e.g., obstructive sleep apnea, restless legs syndrome); 4. Severe hepatic or renal impairment (Child-Pugh class C or eGFR < 60 mL/min/1.73 m^2); 5. Allergy to conductive gel or medical adhesive; 6. Intraoperative conversion to open surgery or planned postoperative ICU admission; 7. Pregnancy or breastfeeding; 8. Participated in other intervention trials in the past three months, etc

Design outcomes

Primary

MeasureTime frame
Postoperative sleep disorder (PSD) incidence (defined as Athens Insomnia Scale (AIS) score =6);

Secondary

MeasureTime frame
Time course of AIS scores;Anxiety level;Perioperative electroencephalogram (EEG) parameters (power spectral density in delta, theta, alpha, sigma, and beta frequency bands, as well as anesthesia awareness index (Ai), electromyography index (EMG), and burst suppression ratio (BSR));Postoperative pain score;Quality of recovery after surgery;Intraoperative hemodynamic parameters (blood pressure, heart rate) and drug consumption (propofol, remifentanil, rocuronium);Surgical duration, anesthesia duration, and extubation time;Postoperative complications (nausea and vomiting, headache and dizziness, discomfort at stimulation site, nightmares, etc.);

Countries

China

Contacts

Public ContactHuang Xunqi

Fujian Maternity and Child Health Hospital

15659037378@163.com+86 156 5903 7378

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 8, 2026